Investment news! Meet Flouria Health

We’re proud to announce our latest investment in Flouria Health. Women’s health is still too often treated as a niche. It isn’t. Conditions related to hormonal health — from perimenopause and postpartum recovery to PCOS — affect millions of women, yet diagnosis is often delayed and access to specialised, continuous care remains limited.

That is exactly the kind of healthcare problem we want to help solve at Healthy.Capital.

Flouria is building a new access layer for women’s hormonal healthcare: combining specialist doctors with a digital care model that supports women from diagnosis and personalised treatment through to ongoing follow-up. The ambition is not simply to add another digital service, but to make specialist care more accessible while using scarce healthcare capacity more effectively.  

With our investment, Flouria has now raised €1.5 million. The funding will support further growth in the Netherlands and lay the groundwork for expansion into other European markets.  

For us, this investment also fits a broader conviction: femtech does not need a lower investment bar. It needs the infrastructure to clear the same bar as every other healthtech company. Better data, better diagnostics, clinical evidence and care pathways that enable successful innovations to scale.

Jeanine van Munster, Vlatko Stojkovski, Anna Christie and the wider Flouria team are taking on a large and historically underserved part of healthcare. We’re excited to support them in building the next phase.

Welcome to the Healthy.Capital portfolio, Flouria. 🌱

For the full announcement, check: https://flouria.health/nl/press/funding-announcement